Nearly 60% of patients taking vibegron remained on treatment at 1 year. The real-world, phase 4 COMPOSUR study (NCT05067478) found that nearly 60% of patients taking vibegron remained on treatment at ...

Panelists discuss how non–muscle-invasive bladder cancer (NMIBC) is staged, graded, and treated according to risk stratification, with detailed explanations of low-, intermediate-, and high-risk ...

Helen Bernie, DO, MPH, joins the show to discuss data from her Indiana University team from the floor at AUA 2025.

Telemedicine has expanded access to urologic oncology care, especially during the COVID-19 pandemic, by enabling remote consultations and treatments. Legislative advancements have supported telehealth ...

Paul E. Dato, MD, discusses how formulation and dosing differences between abiraterone options affect absorption and tolerability, with the micronized version potentially providing better compliance ...

Paul E. Dato, MD, discusses how the presence of a BRCA mutation can influence treatment selection and sequencing, supporting consideration of upfront triplet therapy intensification and planning for ...

Panelists discuss how maintenance BCG therapy and vigilant surveillance are essential for sustaining disease control in NMIBC patients, with treatment schedules and monitoring tailored to individual ...

Panelists discuss how timely identification of BCG-unresponsive NMIBC through defined response criteria enables dynamic risk stratification and guides critical decisions about escalating care to ...

Clinical Brief: Initial Presentation and Management of Metastatic Hormone-Sensitive Prostate Cancer Main Discussion Topics Patient Profile: A 69-year-old Black man presenting with fatigue, nocturnal ...

ACOU085 is a novel otoprotective drug candidate for preventing cisplatin-induced hearing loss in testicular cancer patients. The PROHEAR study involves 40 male patients aged 18-45, receiving high-dose ...

LithoVue Elite's real-time IRP monitoring may expand ureteroscopy to larger stones, improving patient outcomes by reducing complications like bleeding and sepsis. Real-time IRP data aids surgical ...

Investigators found that benefits of treatments that are observed in trials also appear in the real world. A recent study examined the relationship between randomized controlled trials and real-world ...